The synergistic effect between phages and Ceftolozane/Tazobactam in Pseudomonas aeruginosa endotracheal tube biofilm
Although an increased effectiveness has been suggested when phages and antibiotics are combined, this approach has not been tested against a mature biofilm on an endotracheal tube (ETT) surface. This study evaluated the effect of short- and long-term combined phage-antibiotic therapy in a control of...
Saved in:
Main Authors: | Viviane de C. Oliveira, Alba Soler-Comas, Amanda C.S.D. Rocha, Cláudia H. Silva-Lovato, Evandro Watanabe, Antoni Torres, Laia Fernández-Barat |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2420737 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftolozane-tazobactam, ceftazidime-avibactam and ceftazidime-avibactam plus aztreonam combination: Upcoming hope for hospital-acquired MDR/XDR Pseudomonas aeruginosa infections
by: Asmaa Elbrolosy, et al.
Published: (2024-05-01) -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study
by: Francesco Marchesi, et al.
Published: (2020-08-01) -
Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Namareq F. Aldardeer, et al.
Published: (2024-12-01) -
Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms
by: María Fernández-Billón, et al.
Published: (2024-12-01) -
Phages ZC01 and ZC03 require type-IV pilus for Pseudomonas aeruginosa infection and have a potential for therapeutic applications
by: Layla Farage Martins, et al.
Published: (2024-12-01)